SARS-CoV-2疫苗接种和精神药物的血水平:一个前性队列研究
Stefano Ferrea1, Nazar Kuzo1, Giancarlo Giupponi2
1Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.
Expert opinion on drug metabolism & toxicology
|October 14, 2025
概括
在大多数患者中,SARS-CoV-2疫苗接种并没有显著改变精神药物水平. 建议对克洛扎使用者进行监测,因为可能会发生轻微的变化,特别是在没有fluvoxamine的情况下. 这项研究调查了疫苗对精神病治疗药物的影响.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 严重急性呼吸系统综合征 冠状病毒2 (SARS-CoV-2) 感染可以触发影响药物代谢的免疫反应.
- 赛托克P450酶活性可能受到SARS-CoV-2的影响,可能会改变精神药物水平.
- 这项研究旨在评估SARS-CoV-2疫苗接种对精神药物血度的影响.
研究的目的:
- 调查SARS-CoV-2mRNA疫苗接种对精神药物的血水平的影响.
- 检查疫苗诱导的炎症标志物变化与精神药物水平之间的关联.
- 为在COVID-19疫苗接种期间和之后管理精神病药物提供见解.
主要方法:
- 一项前性队列研究,涉及13名接受心理药物治疗的精神病医院住院患者.
- 在接种两剂SARS-CoV-2mRNA疫苗之前和之后采集血样本和炎症标记物 (IL-6,CRP).
- 对各种精神药物的血含量进行分析,包括克洛扎宾,阿里皮普拉,奎平,奥兰扎宾,,塞特拉林,埃斯基塔洛普拉姆,杜洛丁和帕罗克塞丁.
主要成果:
- 接种疫苗后,克洛扎的血水平保持相对稳定,而在不与黄胺联合治疗的患者中,波动更大.
- 观察到介质素6 (IL-6) 和C反应蛋白 (CRP) 水平的轻微变化.
- 在接种疫苗后,阿里皮普拉,奎蒂亚平,奥兰扎平,,塞特拉林,埃斯基塔洛普拉姆,杜洛丁和帕洛丁的血水平没有明显的模式.
结论:
- 接种SARS-CoV-2疫苗通常不会导致精神药物血水平的显著变化.
- 观察到的C-反应蛋白 (CRP) 的增加没有达到通常与药物度升高相关的水平.
- 建议持续监测CRP和药物水平,特别是对于克洛扎接收者,以检测潜在的疫苗后变化.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
Bioavailability Study Design: Healthy Subjects Versus Patients
143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Psychosis and Antipsychotic Drugs: Overview
816
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
816
Drug Distribution: Plasma Protein Binding
8.5K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.5K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


